Navigation Links
Global Immunoassay Systems Market
Date:6/18/2015

NEW YORK, June 18, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 80 companies including many key and niche players such as -

 

Abbott Laboratories
Beckman Coulter, Inc.
bioMérieux SA
Bio-Rad Laboratories Inc.
Ortho-Clinical Diagnostics Inc.

 

Read the full report: http://www.reportlinker.com/p0305127-summary/view-report.html

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Enzyme Immunoassay I-4

Fluorescence Immunoassay I-4

Chemiluminescence Immunoassay I-4

Radioimmunoassay I-4

Nephelometric Immunoassay I-4

 

II. EXECUTIVE SUMMARY

 

1. INDUSTRY OVERVIEW II-1

Immunoassays - A Preface II-1

Current and Future Analysis II-3

Factors Sustaining Market Growth II-3

Factors Restraining Growth II-3

Developing Markets to Turbo Charge Growth in the Market II-4

Innovation - Name of the Game II-4

Automated Multiplexing Platforms Present Growth Opportunities II-5

Improving Healthcare Expenditure to Foster Growth II-6

Table 1: Per-Capita Healthcare Expenditure in Select Regions

(2013) (includes corresponding Graph/Chart) II-6

Table 2: Top 20 Countries with the Highest Healthcare

Spending as a Percentage of GDP: 2012 (includes corresponding

Graph/Chart) II-7

Aging Global Population Buoys Market Growth II-7

Table 3: Global Population Statistics for the 65+ Age Group

(Male & Female) for Major Countries/Regions: 2013E (includes

corresponding Graph/Chart) II-8

Novel Biomarkers & Advanced Technologies to Boost Market II-9

Expanding Immunoassay Applications Boost Demand for

Immunoassay Systems II-9

Table 4: Global Laboratory Based Immunoassay Market (2013):

Percentage Share Breakdown of Value Sales by Clinical Area

(includes corresponding Graph/Chart) II-10

 

2. COMPETITIVE LANDSCAPE II-11

List of Select Commercially Available Immunoassay Instruments II-12

Table 5: Leading Players in the Global Immunoassays Market

for Infectious Diseases (2013) - Percentage Share Breakdown

of Revenues for Siemens, Abbott, Roche, bioMerieux, sorin,

and Others (includes corresponding Graph/Chart) II-12

 

Table 6: Leading Players in the Global Immunoassays Market

for Oncology / Endocrinology (2013) - Percentage Share

Breakdown of Revenues for Siemens, Abbott, Roche, and Others

(includes corresponding Graph/Chart) II-12

New Product Launches Swarm the Market II-13

A Look into New Product Introductions/ Approvals in 2013 II-13

 

3. MARKET TRENDS AND ISSUES II-14

Automated Immunoassay Systems - In Line with Automation Trend II-14

List of Select Automated Immunoassay Instrument Platforms II-15

Shortened Hospital Stays Enhance Significance of Medical Labs II-19

Increasing Use of Immunoassays in Food Sciences and Quality

Control II-19

Growing Use in Environmental Testing II-20

Advancement in Genetic Research Drives the Growth II-20

POC and DIA Systems Grow in Demand II-20

Portable Immunoassay Systems Energizes the Market II-21

Challenges Stifle Bio-Marker Research II-21

Immunochemistry Analyzers: Gaining Traction II-22

 

4. AN INSIGHT INTO IMMUNOASSAY TECHNOLOGIES II-23

Comparison of Various Immunoassay Technologies II-24

ELISA - A Renowned and Proven Assay Format II-24

ELISA Products of Select Manufacturers II-25

Technological Advances to buoy ELISA's Prospects II-26

Automation of ELISA - Enabling its Sustenance II-27

Growing Popularity of Multiplexing Deters ELISA Market II-27

Commoditization: A Key Issue Facing ELISA Product Manufacturers II-27

Radioimmunoassay Systems Lose Sheen II-28

Chemiluminescence Immunoassays Gain Ground II-29

 

5. IMMUNOASSAY APPLICATIONS - A REVIEW II-30

Infectious Disease Diagnosis: The Largest Application Area II-30

Increasing Incidence of Infectious Diseases - An Opportunity

Indicator II-30

Table 7: Reported Cases of Major Infections by Select

Geographic Region: 2011 II-30

Endocrine Testing Procedures II-31

Growing Diabetes Prevalence Boost Prospects for Immunoassay-

based HbA1c Tests II-31

Table 8: Worldwide Prevalence of Diabetes Mellitus by Region

(2013 & 2035) (includes corresponding Graph/Chart) II-33

 

Table 9: Incidence of Diabetes in Select Countries (2013 &

2035) (includes corresponding Graph/Chart) II-33

 

Table 10: World's Health Expenditure on Diabetes by Region

(2013E): Spending (in US$ Billion) by People Diagnosed with

Diabetes in the Age Group 20-79 Years to Treat Diabetes and

Manage Associated Complications (includes corresponding

Graph/Chart) II-34

 

Table 11: Global Expenditure on Diabetes Treatment (2012):

Spending (in US$ Billion) by Income Strata (includes

corresponding Graph/Chart) II-34

Blood Processing Market II-35

Cancer Testing Markets II-35

Drugs of Abuse Testing Market II-35

Therapeutic Drug Monitoring II-36

Immune Disease II-36

Blood Grouping and Typing II-36

Rapid Tests Encroach Allergy Testing Market II-37

 

6. CONCEPTUAL OVERVIEW II-38

Immunoassays - Definition and Description.... II-38

Down the Timeline II-38

Immunoassay Analyzers II-38

Immunoassay Reagents II-39

Radioimmunoassay II-39

Non-Isotopic Immunoassays II-39

Customized Immunoassays II-40

Components of Immunoassays II-40

Signal Response II-40

Labeled Tracer II-40

Binder II-41

Buffer Matrix II-41

Incubation Conditions II-41

Separation Process II-41

Standard Specimens II-41

Control Specimens II-41

Unknown Specimens II-41

Types of Immunoassay Analyzers II-42

Enzyme Immunoassays II-42

Automation Enabled II-43

Customization of Assays II-43

ELISA - A Flexible Enzyme Immunoassay Test..... II-43

Fluorescence Immunoassay - Operating Principle II-44

Light Sources II-44

Sample Cell II-44

Filters II-44

Detector II-45

Time-Resolved Fluoroimmunoassay II-45

Chemiluminescence Immunoassay II-45

Radioimmunoassay Analyzers, Gamma Counters II-46

Fundamentals of Operation II-46

Problems Involved II-47

Types of Immunoassay Techniques II-48

Fluorescence Polarization Immunoassay II-48

Radiative Energy Attenuation (REA) II-49

Substrate-Labeled Fluorescence II-49

Enzyme Immunoassay with Fluorescence Detection II-49

Solid-Phase Microsphere Immunoassay II-50

Microparticle Enzyme Immunoassay (MEIA) II-50

Enzyme-Linked Fluorescence Immunoassay II-50

ELISA With Photometric Detection II-50

Dry-Phase Techniques II-51

Problems and Limitations II-51

Purchase Considerations for Automated Analyzers II-51

 

7. MEDICAL DIAGNOSTICS MARKET - A REVIEW II-53

Clinical Diagnostics Industry - Market Overview and Trends II-53

Global In-Vitro Diagnostics (IVD) Market: A Prelude II-53

Impact of the Recession in Retrospect and the Road Ahead II-54

Factors Influencing IVD Industry: On a Scale of 1-5 II-56

Key Statistical Findings: II-56

Table 12: Global In-Vitro Diagnostics Market by Segment

(2013): Percentage Breakdown of Value Sales for Hematology,

Hemostasis, Immunochemistry, Microbiology, Molecular

Diagnostics, Point-of-Care Diagnostics, Self-Monitoring Blood

Glucose, and Tissue Diagnostics (includes corresponding

Graph/Chart) II-56

 

Table 13: Global In-Vitro Diagnostics Market by Sector

(2013): Percentage Breakdown of Revenues for Decentralized &

Patient Self-Testing and Hospital & Commercial Laboratories

(includes corresponding Graph/Chart) II-57

 

Table 14: World In-Vitro Diagnostic Products Market by Site

of Care (2013) - Percentage Breakdown by Value Sales for

Hospital Labs, Commercial Labs, Self-Testing and POC

(includes corresponding Graph/Chart) II-57

 

Table 15: Global In Vitro Diagnostics (IVD) Market by

Geographic Region (2013): Percentage Share Breakdown of

Revenues for the United States, Europe, and Rest of World

(includes corresponding Graph/Chart) II-57

Molecular Diagnostics - A Replacement and Enabling Technology II-58

 

8. PRODUCT LAUNCHES/APPROVALS II-59

Siemens Introduces New Chemistry & Immunoassay Systems II-59

Meso Scale Discovery Launches S-PLEX™ Assays II-59

Modern Water Monitoring Introduces New Immunoassay Strip Test

and Readers II-59

Enzo Life Sciences Launches Amp'd™ ELISA Signal Amplification Kit II-59

EMD Millipore Rolls Out New Immunoassay Kits II-59

PerkinElmer Launches Novel Research Tools II-59

Roche Releases Elecsys Syphilis Immunoassay II-60

ALPCO Releases STELLUX™ Chemiluminescence Human Total

Proinsulin ELISA II-60

InDevR Introduces miPLEX II-60

Siemens Healthcare Diagnostics Introduces New Alergans and Panels II-60

Randox Introduces New Immunoassay and Analyzer-specific BNP

Liquid Controls II-60

Randox Obtains FDA Approval for Acusera Immunoassay Specialty

1 Control II-60

Meso Scale Rolls Out V-PLEX Biomarker Immunoassays II-61

Abcam Introduces SimpleStep™ ELISA Kits II-61

Quidel Gets FDA Approval for Sofia(R) hCG Fluorescent Immunoassay II-61

Thermo Fisher Scientific Launches New Ready- to-Use Tacroliums

Immunoassay II-61

Meso Scale Discovery Introduces New Quickplex™ SQ 120

Multiplex Immunoassay Instrument II-61

AJ Roboscreen Gets Approval for Two ELISA-based Tests II-61

bioMérieux Launches VIDAS® 3 Automated Immunoassay System II-61

Bio-Rad Introduces New Bio-Plex Pro™ RBM Kidney Toxicity Panels II-62

INOVA Diagnostics Rolls Out BIO-FLASH II-62

Sysmex Introduces HISCL®-5000 II-62

Volition Introduces NuQ Epigenetic Immunoassays II-62

Quidel Obtains CE Mark for Sofia® RSV Fluorescent Immunoassay II-62

Zeus Scientific Gets FDA Approval for ZEUS ELISA™ Borrelia

VlsE1/pepC10 IgG/IgM Test System II-62

Salimetrics Launches Salivary IL-1 Beta Immunoassay Kit II-63

Beckman Coulter Obtains FDA 510(k) Clearance for AU5800

Chemistry Systems II-63

 

9. RECENT INDUSTRY ACTIVITY II-64

Eurofins Acquired ViraCor-IBT Laboratories II-64

YSL Bio Signs Enters into Agreement with GeneX II-64

Techne to Acquire CyVek II-64

Gyros Enters into Distribution Agreement with Tekon Biotech II-64

Singulex Partners with Tecan II-64

OriGene Technologies Takes Over BioCheck II-64

Techne Partners with Fisher Scientific II-65

Invetech Enters into 10-Year Agreement with Bio-Rad II-65

Diaxonhit Enters into Partnership with Tosoh Group II-65

Cisbio Bioassays and Orion Diagnostica Enter into Agreement II-65

Thermo Fisher Scientific and Siemens Renew Existing Agreement II-65

EMD Millipore Enters into Partnership with Gyros II-65

BioVendor Selects SCIENION's Integrated Product Portfolio for

Immunoassays Development II-66

bioMérieux and Quanterix Enter into Strategic Alliance II-66

Trivitron Healthcare and Diasorin Group Form New Joint Venture

Company II-66

Affymetrix Acquires eBioscience Holding Company II-66

Affinity Life Sciences Enters into Partnership with Prediction

Sciences II-66

Vital Diagnostics Inks Exclusive Agreement with Cardinal Health II-66

Gamma Therapeutics Enters into Manufacturing Contract with

ZEUS Scientific II-67

Dynex Technologies Enters into Supply Agreement with Zeus

Scientific II-67

 

10. FOCUS ON SELECT MARKET PARTICIPANTS II-68

Abbott Laboratories (US) II-68

Beckman Coulter, Inc. (US) II-68

bioMérieux SA (France) II-69

Bio-Rad Laboratories Inc. (US) II-69

Ortho-Clinical Diagnostics Inc (US) II-70

Roche Diagnostics (Switzerland) II-71

Siemens Healthcare Diagnostics (US) II-71

Sysmex Corporation (Japan) II-72

Quidel Corporation (US) II-72

DiaSorin S.p.A (Italy) II-73

Fujirebio Inc. (Japan) II-73

Tosoh Bioscience, Inc. (US) II-73

 

11. GLOBAL MARKET PERSPECTIVE II-74

Table 16: World Recent Past, Current & Future Analysis for

Immunoassay Systems by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific, Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) II-74

 

Table 17: World Historic Review for Immunoassay Systems by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,

Latin America and Rest of World Markets Independently Analyzed

with Annual Sales Figures in US$ Thousand for Years 2006

through 2012 (includes corresponding Graph/Chart) II-75

 

Table 18: World 15-Year Perspective for Immunoassay Systems by

Geographic Region - Percentage Breakdown of Value Sales for

US, Canada, Japan, Europe, Asia-Pacific, Latin America and

Rest of World Markets for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) II-76

Immunoassay Systems Market by Product Segment II-77

Table 19: World Recent Past, Current & Future Analysis for

Enzyme Immunoassay Systems by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific, Latin America and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) II-77

 

Table 20: World Historic Review for Enzyme Immunoassay Systems

by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-78

 

Table 21: World 15-Year Perspective for Enzyme Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin

America and Rest of World Markets for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) II-79

 

Table 22: World Recent Past, Current & Future Analysis for

Fluorescence Immunoassay Systems by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of

World Markets Independently Analyzed With Annual Sales Figures

in US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) II-80

 

Table 23: World Historic Review for Fluorescence Immunoassay

Systems by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-81

 

Table 24: World 15-Year Perspective for Fluorescence

Immunoassay Systems by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets for

Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-82

 

Table 25: World Recent Past, Current & Future Analysis for

Chemiluminescence Immunoassay Systems by Geographic Region -

US, Canada, Japan, Europe, Asia-Pacific, Latin America and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) II-83

 

Table 26: World Historic Review for Chemiluminescence

Immunoassay Systems by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific, Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-84

 

Table 27: World 15-Year Perspective for Chemiluminescence

Immunoassay Systems by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets for

Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-85

 

Table 28: World Recent Past, Current & Future Analysis for

Radio Immunoassay Systems by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific, Latin America and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) II-86

 

Table 29: World Historic Review for Radio Immunoassay Systems

by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-87

 

Table 30: World 15-Year Perspective for Radio Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin

America and Rest of World Markets for Years 2006, 2014 & 2020

(includes corresponding Graph/Chart) II-88

 

Table 31: World Recent Past, Current & Future Analysis for

Nephelometric Immunoassay Systems by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) II-89

 

Table 32: World Historic Review for Nephelometric Immunoassay

Systems by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2006 through 2012 (includes corresponding

Graph/Chart) II-90

 

Table 33: World 15-Year Perspective for Nephelometric

Immunoassay Systems by Geographic Region - Percentage

Breakdown of Value Sales for US, Canada, Japan, Europe,

Asia-Pacific, Latin America and Rest of World Markets for

Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-91

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current and Future Analysis III-1

Ageing Demographics: Major Driving Factor III-1

Table 34: North American Elderly Population by Age Group:

1975-2050 (includes corresponding Graph/Chart) III-2

 

Table 35: US Population Breakdown by Age Group: 2012

(includes corresponding Graph/Chart) III-2

Increasing Burden of Chronic Diseases Drives Focus onto

Immunoassays III-3

US In-Vitro Diagnostics Market - A Special Review III-3

Evolving Trends to Benefit IVD Market III-3

An Overview of ELISA Usage III-4

Product Launches/Approvals III-4

Strategic Corporate Developments III-7

Focus on Select Players III-9

B.Market Analytics III-14

Table 36: US Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-14

 

Table 37: US Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-15

Table 38: US 15-Year Perspective for Immunoassay Systems by

Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-16

 

2. CANADA III-17

Market Analysis III-17

Table 39: Canadian Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-18

 

Table 40: Canadian Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-19

 

Table 41: Canadian 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-20

 

3. JAPAN III-21

A.Market Analysis III-21

Outlook III-21

Demographics Drive Market Growth III-21

Table 42: Percentage Breakdown of Japanese Population by

Age Group (2012) (includes corresponding Graph/Chart) III-21

 

Table 43: Japanese 65+ Years Population: 1950-2010

(includes corresponding Graph/Chart) III-22

Product Launch III-22

Focus on Key Players III-22

B.Market Analytics III-24

Table 44: Japanese Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-24

 

Table 45: Japanese Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-25

 

Table 46: Japanese 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-26

 

4. EUROPE III-27

A.Market Analysis III-27

Current & Future Analysis III-27

Automation Supports Growth in Western European IVD Market III-27

Immunochemistry Analyzer Market III-27

Rationing Healthcare System Impacts Growth III-28

Trends in Immunodiagnostic Market..... III-30

Increasing Testing Needs of the Elderly: Business Case for

Immunoassays III-30

Table 47: Population Breakup by Age Group for Select

European Countries: 2012 (As a % of Total Population)

(includes corresponding Graph/Chart) III-31

Product Launch III-32

B.Market Analytics III-32

Table 48: European Recent Past, Current & Future Analysis

for Immunoassay Systems by Geographic Region - France,

Germany, Italy, the UK, Spain, Russia and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Thousand for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-32

 

Table 49: European Historic Review for Immunoassay Systems

by Geographic Region - France, Germany, Italy, the UK,

Spain, Russia and Rest of Europe Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-33

Table 50: European Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-34

 

Table 51: European Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-35

 

Table 52: European 15-Year Perspective for Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for France, Germany, Italy, the UK, Spain, Russia and

Rest of Europe Markets for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-36

 

Table 53: European 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for Years 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-37

 

4a. FRANCE III-38

A.Market Analysis III-38

Current & Future Analysis III-38

Product Launch III-38

Strategic Corporate Development III-38

bioMérieux - A Key Player III-38

B.Market Analytics III-40

Table 54: French Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-40

 

Table 55: French Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-41

 

Table 56: French 15-Year Perspective for Immunoassay Systems

by Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-42

 

4b. GERMANY III-43

A.Market Analysis III-43

Current & Future Analysis III-43

Product Launches III-43

B.Market Analytics III-44

Table 57: German Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-44

 

Table 58: German Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-45

 

Table 59: German 15-Year Perspective for Immunoassay Systems

by Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-46

 

4c. ITALY III-47

A.Market Analysis III-47

DiaSorin S.p.A - A Key Player III-47

B.Market Analytics III-48

Table 60: Italian Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-48

 

Table 61: Italian Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-49

 

Table 62: Italian 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-50

 

4d. THE UNITED KINGDOM III-51

A.Market Analysis III-51

Current & Future Analysis III-51

Product Launches III-51

B.Market Analytics III-52

Table 63: UK Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-52

 

Table 64: UK Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-53

 

Table 65: UK 15-Year Perspective for Immunoassay Systems by

Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-54

 

4e. SPAIN III-55

Market Analysis III-55

Table 66: Spain Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-55

 

Table 67: Spain Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-56

 

Table 68: Spain 15-Year Perspective for Immunoassay Systems

by Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-57

 

4f. RUSSIA III-58

Market Analysis III-58

Table 69: Russian Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-58

 

Table 70: Russian Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-59

 

Table 71: Russian 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-60

 

4g. REST OF EUROPE III-61

A.Market Analysis III-61

Current and Future Analysis III-61

Product Launches III-61

Strategic Corporate Developments III-61

Roche Diagnostics - A Key Player III-62

B.Market Analytics III-63

Table 72: Rest of Europe Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-63

 

Table 73: Rest of Europe Historic Review for Immunoassay

Systems by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-64

 

Table 74: Rest of Europe 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-65

 

5. ASIA-PACIFIC III-66

A.Market Analysis III-66

Current and Future Analysis III-66

Growing In-Vitro Diagnostics (IVD) Market Fuels Demand for

Immunoassay Instruments III-66

India & China Offer Significant Growth Opportunities III-66

Table 75: China and India Leads Global Population (July

2013): Table Depicting China and India's Huge Population

Vis-a-vis Other Countries' Population (in Million) by Age

Group (includes corresponding Graph/Chart) III-67

 

Table 76: Age-wise Breakup of China and India's Population

Vis-à-vis Other Populous Countries Globally: As of July

2013 (includes corresponding Graph/Chart) III-68

Healthcare Spending in Asia-Pacific: On the Rise III-68

Product Registration: A Major Roadblock III-69

Distribution: A Major Challenge III-69

B.Market Analytics III-70

Table 77: Asia-Pacific Recent Past, Current & Future

Analysis for Immunoassay Systems by Geographic Region -

China, India and Rest of Asia-Pacific Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-70

 

Table 78: Asia-Pacific Historic Review for Immunoassay

Systems by Geographic Region - China, India and Rest of

Asia-Pacific Markets Independently Analyzed with Annual

Sales Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-71

 

Table 79: Asia-Pacific Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-72

 

Table 80: Asia-Pacific Historic Review for Immunoassay

Systems by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-73

 

Table 81: Asia-Pacific 15-Year Perspective for Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for China, India and Rest of Asia-Pacific Markets for

Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-74

 

Table 82: Asia-Pacific 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-75

 

5a. CHINA III-76

A.Market Analysis III-76

Current and Future Analysis III-76

In-Vitro Diagnostics Market on the Growth Curve III-76

Table 83: Leading Vendors in the Chinese IVD Market

(2013): Percentage Market Share Breakdown for Abbott,

Beckman/Danaher, bioMerieux, DAAN, Hitachi, J&J, Mindray,

Roche, Siemens, Sysmex and Others (includes corresponding

Graph/Chart) III-77

Diagnostics Products Market in China: A Review III-77

Competitive Analysis III-77

B.Market Analytics III-79

Table 84: Chinese Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-79

 

Table 85: Chinese Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-80

 

Table 86: Chinese 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-81

 

5b. INDIA III-82

A.Market Analysis III-82

Current and Future Analysis III-82

IVD Market in India: An Overview III-82

Immunoassays Market - An Overview III-82

Emerging Trends III-83

Competitive Scenario III-84

Leading Vendors of Immunochemistry Instruments and Reagents

in India III-84

Leading ELISA Kits Vendors in India III-84

Leading Vendors of Rapid Tests in India III-84

B.Market Analytics III-85

Table 87: Indian Recent Past, Current & Future Analysis for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-85

 

Table 88: Indian Historic Review for Immunoassay Systems by

Product Segment - Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-86

 

Table 89: Indian 15-Year Perspective for Immunoassay Systems

by Product Segment - Percentage Breakdown of Value Sales for

Enzyme Immunoassay Systems, Fluorescence Immunoassay

Systems, Chemiluminescence Immunoassay Systems, Radio

Immunoassay Systems, and Nephelometric Immunoassay Systems

Markets for 2006, 2014 & 2020 (includes corresponding

Graph/Chart) III-87

 

5c. REST OF ASIA-PACIFIC III-88

A.Market Analysis III-88

Current and Future Analysis III-88

Indonesia III-88

Malaysia III-88

Strategic Corporate Developments III-88

B.Market Analytics III-90

Table 90: Rest of Asia-Pacific Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-90

 

Table 91: Rest of Asia-Pacific Historic Review for

Immunoassay Systems by Product Segment - Enzyme Immunoassay

Systems, Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-91

 

Table 92: Rest of Asia-Pacific 15-Year Perspective for

Immunoassay Systems by Product Segment - Percentage

Breakdown of Value Sales for Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets for 2006, 2014 &

2020 (includes corresponding Graph/Chart) III-92

 

6. LATIN AMERICA III-93

Market Analysis III-93

Table 93: Latin American Recent Past, Current & Future

Analysis for Immunoassay Systems by Geographic Region -

Brazil and Rest of Latin American Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2013 through 2020 (includes corresponding Graph/Chart) III-93

 

Table 94: Latin American Historic Review for Immunoassay

Systems by Geographic Region - Brazil and Rest of Latin

American Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2006 through 2012

(includes corresponding Graph/Chart) III-94

 

Table 95: Latin American Recent Past, Current & Future

Analysis for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-95

 

Table 96: Latin American Historic Review for Immunoassay

Systems by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-96

 

Table 97: Latin American 15-Year Perspective for Immunoassay

Systems by Geographic Region - Percentage Breakdown of Value

Sales for Brazil and Rest of Latin American Markets for

Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-97

 

Table 98: Latin American 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-98

 

6a. BRAZIL III-99

Market Analysis III-99

Table 99: Brazilian Recent Past, Current & Future Analysis

for Immunoassay Systems by Product Segment - Enzyme

Immunoassay Systems, Fluorescence Immunoassay Systems,

Chemiluminescence Immunoassay Systems, Radio Immunoassay

Systems, and Nephelometric Immunoassay Systems Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-99

 

Table 100: Brazilian Historic Review for Immunoassay Systems

by Product Segment - Enzyme Immunoassay Systems,

Fluorescence Immunoassay Systems, Chemiluminescence

Immunoassay Systems, Radio Immunoassay Systems, and

Nephelometric Immunoassay Systems Markets Independently

Analyzed with Annual Sales Figures in US$ Thousand for Years

2006 through 2012 (includes corresponding Graph/Chart) III-100

 

Table 101: Brazilian 15-Year Perspective for Immunoassay

Systems by Product Segment - Percentage Breakdown of Value

Sales for Enzyme Immunoassay Systems, Fluorescence

Immunoassay Systems, Chemiluminescence Immunoassay Systems,

Radio Immunoassay Systems, and Nephelometric Immunoassay

Systems Markets for 2006, 2014 & 2020 (includes

corresponding Graph/Chart) III-101

 

6b. REST OF LATIN AMERICA III-102

Market Analysis III-102

Table 102

Read the full report: http://www.reportlinker.com/p0305127-summary/view-report.html

 

About Reportlinker

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

 

http://www.reportlinker.com

 

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2015 PR Newswire.
All rights reserved


Related biology news :

1. Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020
2. Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4%
3. Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis
4. Global Genetic Testing Market Outlook 2018
5. Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm
6. Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research
7. Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships
8. Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating
9. Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control
10. Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector
11. Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2019)... ... July 31, 2019 , ... Molecular Devices, LLC, a leader ... generation of its FLIPR® Penta High-Throughput Cellular Screening System. , The new FLIPR ... of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option ...
(Date:7/26/2019)... ... July 25, 2019 , ... Lemnis ... mixed reality headsets to include a new generation eye tracker with hassle-free calibration. ... Los Angeles, California (July 30 - August 1). SIGGRAPH attendees will be able ...
(Date:7/23/2019)... ... July 23, 2019 , ... NanoFUSE is ... biologic strip indicated for spine and orthopedic use. Bioactive glass is a calcium ... has been clinically-proven in orthopedics for over 30 years and now NanoFUSE Biologics ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... ... technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings ... and will educate viewers about how its technology facilitates laboratories to improve efficiency ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Clinic, a national leader in opioid treatment, announced today they are partnering to ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic to ...
(Date:6/11/2019)... ... June 11, 2019 , ... A ... mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying ... on mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of cancer ... breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor ... T cell receptors known as “CARs”. The CAR enables the final product to produce ...
Breaking Biology Technology: